Swiss Re Updates Life Guide with Underwriting Guidance on Longevity Drugs
Swiss Re's August 2025 Life Guide update provides U.S. life insurers with new underwriting guidance on repurposed longevity drugs like metformin and rapamycin, enhancing risk assessment for evolving health trends.